Anisakiasis is a zoonotic nematode infection that causes acute and chronic gastrointestinal granulomatous disease in humans. For most patients, the causative agents are larvae of nematodes of the genera *Anisakis* and *Pseudoterranova*, and the source of infection is marine fish or squids harboring these larvae ([@R1]). Within 8--12 hours after infected fish are ingested, the larvae penetrate into the person's stomach or intestinal wall, causing acute abdominal pain, indigestion, nausea, and vomiting; pathologic findings are edema, hyperemia, and bleeding in the surrounding mucosa ([@R1],[@R2]). The diagnosis is usually based on morphologic identification of the larvae or on histopathologic identification of sectioned larvae ([@R1]). However, molecular techniques have recently been developed as effective tools not only for the diagnosis of individual cases but also for studies of taxonomy and evolution of anisakid nematodes ([@R3],[@R4]).

Anisakiasis in humans was first reported in the Netherlands; since then, it has been reported extensively in Japan (≈2,000 cases annually), South Korea (≈200 cases annually), and some European countries (≈500 cases annually) where people eat raw or undercooked fish ([@R1],[@R2]). In the United States, up to 50 human cases are reported each year ([@R1]). Most infections in humans have been caused by *Anisakis simplex* sensu stricto and *Pseudoterranova decipiens* nematodes ([@R1]); however, since 1999, a few human infections with *Anisakis pegreffii* larvae (a sibling species of *A. simplex* s.s.), originally recovered from a Mediterranean monk seal ([@R5]), have been reported in Italy ([@R6]--[@R9]) and Japan ([@R10],[@R11]). The larvae of *A. pegreffii* are morphologically distinguished, with difficulty, from those of *A. simplex* s.s. (both are *Anisakis* type I); however, molecular techniques can easily distinguish the 2 types of larvae ([@R3],[@R4]).

In South Korea, *Anisakis* type I larvae recovered from humans and fish have been assigned to *A. simplex* s.s., on the basis of morphologic appearance ([@R1],[@R12]). We performed molecular analyses of 26 *Anisakis* type I larvae recovered from 16 humans in South Korea by using DNA sequencing of the nuclear internal transcribed spacer (ITS) genes.

The Study
=========

A total of 30 *Anisakis* type I larvae were removed from the stomach of 16 patients referred to the Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul, South Korea, from 2000 through 2013 ([Table](#T1){ref-type="table"}). Among them, 26 larvae were analyzed by DNA sequencing. All patients experienced acute gastric or abdominal discomfort, including epigastric pain and indigestion, and underwent gastroduodenoscopy. During the examinations, whitish nematode larvae were observed and extracted with biopsy forceps. Some larvae were preserved in 70% ethanol, and others were fixed in 10% formalin before being mounted on slides with glycerin jelly.

###### Anisakiasis characteristics among 16 human patients, South Korea, 2000--2013\*

  Patient no.   Patient sex   Year of larvae recovery   No. larvae recovered   Clinical signs and symptoms                                              *Anisakis* larvae sequencing results (% identical sites)   
  ------------- ------------- ------------------------- ---------------------- ------------------------------------------------------------------------ ---------------------------------------------------------- ------
  1             M             2000                      1                      Abdominal pain, nausea                                                   99.2                                                       100
  2             M             2000                      1                      Indigestion, vague gastric pain                                          99.2                                                       100
  3             M             2002                      1                      Abdominal pain, nausea, vomiting                                         99.2                                                       100
  4             F             2002                      1                      Abdominal pain and tenderness, anorexia                                  99.2                                                       100
  5             F             2003                      1                      Epigastric pain, nausea, vomiting                                        99.2                                                       100
  6             M             2003                      1                      Abdominal pain, indigestion                                              99.2                                                       100
  7             F             2003                      1                      Abdominal pain, nausea, diarrhea                                         99.2                                                       100
  8             F             2003                      1                      Abdominal pain, nausea, anorexia                                         99.2                                                       100
  9             F             2004                      1                      Epigastric pain, abdominal fullness                                      99.2                                                       100
  10            M             2005                      1                      Abdominal pain, nausea, vomiting                                         99.2                                                       100
  11            F             2005                      1                      Abdominal pain, indigestion, nausea, vomiting                            99.2                                                       100
  12            M             2005                      1                      Abdominal pain, nausea, vomiting                                         99.2                                                       100
  13            M             2005                      1                      Epigastric pain, indigestion, nausea                                     99.2                                                       100
  14            M             2006                      1                      Abdominal discomfort, nausea                                             99.2                                                       100
  15            M             2012                      1                      Abdominal pain and tenderness                                            100                                                        99.2
  16            M             2013                      15†                    Abdominal pain and tenderness, indigestion, nausea, vomiting, anorexia   99.2                                                       100

\*All patients underwent gastroduodenoscopy, during which *Anisakis* larvae were removed with biopsy forceps. †Of these 15 larvae, 11 were analyzed by use of molecular techniques.

Total genomic DNA was extracted by using a DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany); nested PCR and nucleotide sequencing were performed on the ITS region (ITS1, 5.8S rRNA subunit, and ITS2) according to procedures reported previously ([@R13]). The PCR product was amplified by using the Cosmo Labopass X2 PCR Premix kit (Cosmo Genetech, Seoul, South Korea), and automated DNA sequencing was performed by Solgent Co., Ltd. (Daejeon, South Korea). Nucleotide sequences obtained were aligned by using the Geneious program, version 6.0.3 (Geneious Co., Wellington, New Zealand).

Of the 26 *Anisakis* larvae from 15 human patients, 25 showed 100% identity in the sequences of ITS region (244 bp, high-confidence variable positions) with those of the *A. pegreffii* sequence available in GenBank (accession no. AB277823), whereas their identity with *A. simplex* s.s. (accession no. AB277822) was 99.2% ([Table](#T1){ref-type="table"}). The remaining sample showed 100% identity with the sequences of *A. simplex* s.s. (accession no. AB277822) and 99.2% identity with those of *A. pegreffii* (accession no. AB277823). On the basis of these results, *A. pegreffii* nematode infection was diagnosed for 15 of the 16 patients, and *A. simplex* s.s. infection was diagnosed for only 1 patient.

Conclusions
===========

Our results confirm the presence of *A. pegreffii* nematode infection in humans in South Korea, making this the third country (after Italy and Japan) in which this infection in humans has been identified. This high proportion of *A. pegreffii* nematode infections in humans is surprising and suggests that most cases of anisakiasis in humans in South Korea may be caused by *A. pegreffii* rather than *A. simplex* s.s. larvae. To confirm the source of infection, molecular analyses of *Anisakis* larvae extracted from human patients are required in South Korea.

Human infection with *A. pegreffii* nematodes was first documented in Italy by use of PCR-based restriction fragment length polymorphism (PCR-RFLP) analysis ([@R6]). The second case was reported from Japan ([@R10]), in which 1 of 100 anisakid larvae extracted from patients in Kyushu and Hokkaido was identified by PCR-RFLP analysis as *A. pegreffii*. Then, in 2009, *A. pegreffii* nematode infection was diagnosed for 2 women in Italy by PCR-RFLP and sequencing of the 28S gene ([@R7]). In 2011, *A. pegreffii* DNA was extracted from a paraffin-embedded granuloma from a man in Italy ([@R8]). Also in Italy, 8 more *A. pegreffii* nematode infections in humans were reported in 2013 ([@R9]). Thus, to date, including the 15 cases reported here, a total of 28 cases of *A. pegreffii* nematode infections in humans have been documented in the literature.

The markedly high proportion of *A. pegreffii* nematode infections identified among patients in South Korea (25/26 larvae from 15/16 patients) was not expected because in Japan (Kyushu and Hokkaido), which are geographically close to South Korea, *Anisakis* larvae from humans are mostly *A. simplex* s.s. (99/100 larvae from 84/85 patients); only 1 larva was identified as *A. pegreffii* ([@R10]). This remarkable discrepancy between South Korea and Japan remains to be further investigated. However, it is of note that the species of *Anisakis* larvae detected in fish varied according to the 2 large localities of Japan; from northern Japan to the Pacific sides and from the Sea of Japan to the eastern China Sea sides ([@R14]). The former locality, such as Hokkaido and eastern Japan, showed more *A. simplex* s.s. than *A. pegreffii* larvae, whereas the latter locality (southwestern Japan), including Kyushu and Fukuoka (close to South Korea), showed more *A. pegreffii* than *A. simplex* s.s larvae ([@R14]). This finding might partly explain the discrepancy between the *Anisakis* larvae species that infect humans in South Korea and Japan.

When the pathogenic potential of *A. simplex* s.s. larvae for human patients was compared with that of *A. pegreffii* ([@R11]), it was found that *A. simplex* s.s. larvae had greater potential than *A. pegreffii* larvae to survive acidic gastric juice and to penetrate the human stomach, small intestine, and colon. However, further studies are needed to elucidate this finding.

Another clinicopathologic concern associated with anisakiasis in humans is the potential for *A. simplex* s.s. and *A. pegreffii* larvae to elicit gastroallergic reactions. These reactions are characterized by urticaria on the arms and abdomen and by angioedema or anaphylaxis when the live parasite attempts to penetrate the gastric mucosa ([@R9]). We did not notice such allergic reactions in the patients reported here. However, because of an increasing tendency toward *Anisakis* nematode allergy among patients in South Korea ([@R15]), attention should be paid to this clinical feature.

Our study demonstrates the predominance of *A. pegreffii* over *A. simplex* s.s. nematode infection among humans with anisakiasis in South Korea. The study highlights the need to perform molecular analysis for each larva extracted from human patients in this country.
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